RxDoctor Payments Data

Amy Price, PA

Physician Assistant · Omaha, NENPI 1245537067

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.3% of the total across 398 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 14.9% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in NE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,384in general payments, 2019–2025

Across 398 payments — averaging $21.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Johnson & Johnson$871
  • Lilly USA, LLC$822
  • Sanofi$741
  • Regeneron Healthcare Solutions, Inc.$706
  • Novartis$609
  • plus $3K from 26 others

What the payments were for

  • Food & beverage$7,90394%
  • Education$4816%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,384 in reported general payments places this provider in the 95th percentile of 1,127 physician assistant providers in Nebraska.

See all physician assistant providers in Nebraska

Medicare billing

Part B allowed, 2024
$85,032
Medicare patients
258
Services billed
1,812

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab11$48,057
Dupixent SyringeDupilumab13$47,695
Ketoconazole82$1,475
Clobetasol Propionate24$1,375
Dutasteride41$695
ValacyclovirValacyclovir Hcl12$397
Minoxidil42$245
Mupirocin28$222
Spironolactone19$191
Triamcinolone Acetonide25$162
Terbinafine Hcl18$98

Paid to pharmacies, not to this prescriber.

Other physician assistant in Omaha

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →